Metsera

Metsera EBIT Growth

Delisted

The Year-over-Year EBIT Growth of Metsera (MTSR) as of Nov 4, 2026 is -414.86 %. In the previous year, Year-over-Year EBIT Growth was -6,447.08 % — a change of -93.57% (higher).

EBIT Growth

-414.86 %

YoY

-93.57%

Last updated:

Year-over-Year EBIT Growth of Metsera is 2024 -414.86 % . Year-over-Year EBIT Growth of Metsera was 2023 -6,447.08 % . It decreases by -93.57% higher compared to the previous year.

The Metsera EBIT Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Growth
Date
EBIT Growth
Jan 1, 2023
-6,447.08 USD
Jan 1, 2024
-414.86 USD
The Metsera EBIT Growth history
YEAREBIT GrowthYoY
-414.86 %-93.57%
-6,447.08 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Metsera Stock analysis

What does Metsera do? Metsera Inc. is a clinical stage biopharmaceutical company based in New York City, operating in the Health Care sector with a focus on Biotechnology. The company develops next-generation injectable and oral nutrient stimulated hormone (NuSH) analog peptides for treating obesity and related conditions. Utilizing its proprietary MINT peptide library, HALO half-life extension platform, and MOMENTUM oral delivery system, Metsera has a pipeline including MET-097i, MET-233i, and MET-224o, targeting various obesity treatments with differentiated approaches. Listed on 31 January 2025, the company employs 82 staff. Metsera is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Metsera stock

Year-over-Year EBIT Growth of Metsera is -414.86 % in 2024.

On Eulerpool you can find the complete historical development of Year-over-Year EBIT Growth Metsera since 2006 – with annual values, charts, and detailed analysis.

EBIT growth measures the percentage change in operating earnings. It shows whether a company's core operations are becoming more profitable.

To evaluate Year-over-Year EBIT Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBIT Growth.

Year-over-Year EBIT Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBIT Growth's Metsera historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Metsera

All Key Metrics — Metsera